MDT

89.42

+0.45%↑

VEEV

284.11

+0.3%↑

A

124.34

+2.53%↑

WBA

11.54

-0.09%↓

HQY

98.16

-1.3%↓

MDT

89.42

+0.45%↑

VEEV

284.11

+0.3%↑

A

124.34

+2.53%↑

WBA

11.54

-0.09%↓

HQY

98.16

-1.3%↓

MDT

89.42

+0.45%↑

VEEV

284.11

+0.3%↑

A

124.34

+2.53%↑

WBA

11.54

-0.09%↓

HQY

98.16

-1.3%↓

MDT

89.42

+0.45%↑

VEEV

284.11

+0.3%↑

A

124.34

+2.53%↑

WBA

11.54

-0.09%↓

HQY

98.16

-1.3%↓

MDT

89.42

+0.45%↑

VEEV

284.11

+0.3%↑

A

124.34

+2.53%↑

WBA

11.54

-0.09%↓

HQY

98.16

-1.3%↓

Search

Assertio Holdings Inc

Open

0.69 1.47

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.67

Max

0.7

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.1M

-14M

Verkäufe

-5.7M

26M

Gewinnspanne

-51.121

Angestellte

58

EBITDA

-10M

-13M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+305.8% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

6. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

3.9M

63M

Vorheriger Eröffnungskurs

-0.78

Vorheriger Schlusskurs

0.69

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Assertio Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

9. Juli 2025, 15:46 UTC

Wichtige Markttreiber

BitMine Shares Fall After Closing of $250 Million Private Placement

9. Juli 2025, 23:44 UTC

Market Talk

Gold Edges Higher Amid U.S. Tariff Concerns -- Market Talk

9. Juli 2025, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Juli 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound as U.S. Tariff Uncertainty Continues -- Market Talk

9. Juli 2025, 22:59 UTC

Market Talk

Reliance Worldwide's Costs at Risk From Copper Tariffs -- Market Talk

9. Juli 2025, 22:59 UTC

Market Talk

Global Equities Roundup: Market Talk

9. Juli 2025, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juli 2025, 20:26 UTC

Ergebnisse

Nvidia Is the Most Valuable Company Ever. Why $5 Trillion Could Be Next. -- Barrons.com

9. Juli 2025, 19:18 UTC

Market Talk

Oil Futures End Little Changed After Big U.S. Crude Stock Build -- Market Talk

9. Juli 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Losses -- Market Talk

9. Juli 2025, 18:31 UTC

Market Talk

Some Fed Officials Supported Considering July Cut -- Market Talk

9. Juli 2025, 17:07 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Honeywell's Streamlining Efforts Clear Path for Stock to Catch Up -- Market Talk

9. Juli 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk -2-

9. Juli 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9. Juli 2025, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

9. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9. Juli 2025, 16:14 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. Juli 2025, 16:14 UTC

Market Talk

Rents in Canada Soften For Ninth-Straight Month -- Market Talk

9. Juli 2025, 16:14 UTC

Akquisitionen, Fusionen, Übernahmen

Apple Has Dropped the Ball on AI. Buying Perplexity Could Help It Catch Up, Say Analysts. -- Barrons.com

9. Juli 2025, 16:12 UTC

Market Talk

Gold Futures Broadly Flat in Largely Directionless Trade -- Market Talk

9. Juli 2025, 16:08 UTC

Market Talk

Oil Ticks Higher Amid Large U.S. Crude Build, Red Sea Tensions, Tariff Uncertainty -- Market Talk

9. Juli 2025, 15:31 UTC

Wichtige Markttreiber

BitMine Shares Fall After Closing of $250M Private Placement

9. Juli 2025, 15:31 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

With Competing Bids Unlikely, Merck's Path to Acquiring Verona Looks Smooth -- Market Talk

9. Juli 2025, 15:27 UTC

Market Talk

Copper Rally Expected to Fade Amid Tepid Global Demand -- Market Talk

9. Juli 2025, 14:36 UTC

Akquisitionen, Fusionen, Übernahmen

Merck to Buy Verona Pharma in $10 Billion Deal -- 2nd Update

9. Juli 2025, 14:31 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9. Juli 2025, 14:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

9. Juli 2025, 14:26 UTC

Market Talk

Aug 1 Tariffs Will Boost Average Rate Near 15%, JPMorgan Estimates -- Market Talk

Peer-Vergleich

Kursveränderung

Assertio Holdings Inc Prognose

Kursziel

By TipRanks

305.8% Vorteil

12-Monats-Prognose

Durchschnitt 2.8 USD  305.8%

Hoch 3.5 USD

Tief 1.5 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Assertio Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

4

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

0.618 / 0.649Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.